When a patient schedules an appointment and does not keep it, he/she is denying another student access to our services. If you need to cancel or change your appointment you must do this at least one hour prior to the scheduled appointment time. If an appointment is cancelled less than one hour prior to the appointment time or the patient doesn’t arrive, it is nearly impossible for us to offer this time to another patient that needs to be seen. Appointments not canceled at least one hour before the scheduled appointment time will be charged a $15 fee. If you are more than 10 minutes late for your appointment, we regret that we will not be able to hold your appointment time and you will be charged a $15 missed appointment fee.
Two undergraduate students at Rutgers University-New Brunswick were diagnosed with invasive meningococcal disease, serogroup B, in March and April. Both students have since recovered and neither has any sequelae. Meningococcal bacteria are spread from person to person through exchange of respiratory secretions during close or lengthy contact. The bacteria are commonly carried in the nasopharynx, and most persons do not have symptoms while carrying the bacteria. Patients with invasive meningococcal disease can deteriorate rapidly if untreated. Living in dormitory-style housing and having a high degree of social mixing are considered risk factors for developing meningococcal disease. Vaccination is the best protection against meningococcal disease. However, the standard meningococcal vaccine required of Drew’s residential students protects against serogroups of meningococcal bacteria A, C, W, and Y, but not against serogroup B. Persons not affiliated with the Rutgers University-New Brunswick campus are not recommended to receive the Meningitis B (Men B) vaccine specifically in response to this outbreak. However, unrelated to this outbreak, the Advisory Committee on Immunization Practices (ACIP) states that providers should vaccinate persons with high risk conditions and occupations. (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6422a3.htm) and, per a Category B recommendation, may vaccinate any person aged 16–23 years with MenB vaccine(http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6441a3.htm). At this time […]
Countries with a high incidence of TB